Founded in 2008, Inveready Technology Investment Group is a venture capital investment firm based in Barcelona, Spain. The firm seeks to invest in the technology, biotechnology, clean-tech, information technology, and healthcare sectors.
Inveready Technology Investment Group invest through 4 verticals (Venture Capital in Digital Technology, Venture Capital in Life Sciences, Venture Debt and Hybrid Financing for quoted companies in growth markets), with over €330 million of assets under management.
Inveready Technology Investment Group has made investments in Ability Pharmaceuticals, VIVEbiotech, VOLAVA, ProntoPiso, Foxtenn, Zinklar, HETIKUS, Spiral Therapeutics, Clerhp and Beezy.
They exited their investments in Minoryx Therapeutics, AVX Pharma, 3scale, Sweetspot, Agile Content, Edesa Biotech, GIGAS, Respiro, iSalud.com, eyeOS and MyTwinPlace.
